These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6405774)

  • 1. Transplacental passage and half-life of sodium valproate in infants born to epileptic mothers.
    Kaneko S; Otani K; Fukushima Y; Sato T; Nomura Y; Ogawa Y
    Br J Clin Pharmacol; 1983 Apr; 15(4):503-6. PubMed ID: 6405774
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.
    Nau H; Rating D; Koch S; Häuser I; Helge H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal fibrinogen depletion caused by sodium valproate.
    Bavoux F; Fournier-Perhilou AI; Wood C; Francoual C; Boccara JF
    Ann Pharmacother; 1994 Nov; 28(11):1307. PubMed ID: 7849355
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible teratogenic effect of valproate during pregnancy.
    Koch S; Jäger-Roman E; Rating D; Helge H
    J Pediatr; 1983 Dec; 103(6):1007-8. PubMed ID: 6417292
    [No Abstract]   [Full Text] [Related]  

  • 5. Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate.
    Tsuru N; Maeda T; Tsuruoka M
    Jpn J Psychiatry Neurol; 1988 Mar; 42(1):89-96. PubMed ID: 3135429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of valproate during pregnancy, in the newborn and in breast milk.
    Philbert A; Pedersen B; Dam M
    Acta Neurol Scand; 1985 Nov; 72(5):460-3. PubMed ID: 3936331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2005 Oct; 46(10):1621-4. PubMed ID: 16190933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproic acid concentration in the blood serum of pregnant women and umbilical cord blood in relation to the condition of the newborn--case studies].
    Kulza M; Miller R; Wozniak A; Napierała M; Wachowiak A; Hassan-Bartz M; Krzyścin M; Chuchracki M; Breborowicz GH; Florek E
    Przegl Lek; 2013; 70(10):842-7. PubMed ID: 24501809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of diphenylhydantoin metabolites in newborn infants.
    Rane A
    J Pediatr; 1974 Oct; 85(4):543-5. PubMed ID: 4475101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
    Thisted E; Ebbesen F
    Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
    Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
    Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Condition of newborn infants born to epileptic mothers].
    Mikulska M; Rokicki W; Cichoń-Wardas D; Ulfik B
    Pediatr Pol; 1982; 57(5-6):415-20. PubMed ID: 6891454
    [No Abstract]   [Full Text] [Related]  

  • 13. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
    Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H
    Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746
    [No Abstract]   [Full Text] [Related]  

  • 14. [The first case of a child born with fetal valproic acid syndrome in Hungary].
    Robinek F; Czeizel E
    Orv Hetil; 1989 Jan; 130(5):267. PubMed ID: 2492655
    [No Abstract]   [Full Text] [Related]  

  • 15. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
    Hockey A; Bower C; Goldblatt J; Knowles S
    Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is valproic acid teratogenic?].
    Robert E; Robert JM; Lapras C
    Rev Neurol (Paris); 1983; 139(6-7):445-7. PubMed ID: 6412342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal epilepsy, valproate exposure, and birth defects.
    Mastroiacovo P; Bertollini R; Morandini S; Segni G
    Lancet; 1983 Dec 24-31; 2(8365-66):1499. PubMed ID: 6140587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fetal valproate syndrome].
    Houge G; Fiskerstrand T; Øyen N
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2331. PubMed ID: 14508573
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fetal valproate syndrome].
    Taubøll E; Gjerstad L; Henriksen T; Husby H
    Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2765. PubMed ID: 14600761
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate and spina bifida.
    Oakeshott P
    Practitioner; 1989 Sep; 233(1474):1129. PubMed ID: 2515531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.